Paul L. M. van Giersbergen
Actelion Pharmaceuticals Ltd
Department of Clinical Pharmacology
Gewerbestrasse 16
4123 Allschwil
Switzerland
Name/email consistency: high
- Influence of food intake on the pharmacokinetics of miglustat, an inhibitor of glucosylceramide synthase. van Giersbergen, P.L., Dingemanse, J. J. Clin. Pharmacol (2007)
- Inhibitory and inductive effects of rifampin on the pharmacokinetics of bosentan in healthy subjects. van Giersbergen, P.L., Treiber, A., Schneiter, R., Dietrich, H., Dingemanse, J. Clin. Pharmacol. Ther. (2007)
- Tolerability, pharmacokinetics, and pharmacodynamics of clazosentan, a parenteral endothelin receptor antagonist. van Giersbergen, P.L., Dingemanse, J. Eur. J. Clin. Pharmacol. (2007)
- Pharmacokinetic interaction between bosentan and the oral contraceptives norethisterone and ethinyl estradiol. van Giersbergen, P.L., Halabi, A., Dingemanse, J. Int. J. Clin. Pharmacol. Ther (2006)
- Effect of severe renal impairment on the pharmacokinetics and tolerability of the parenteral endothelin antagonist tezosentan. van Giersbergen, P.L., Dingemanse, J. Int. J. Clin. Pharmacol. Ther (2003)
- Determination of tezosentan, a parenteral endothelin receptor antagonist, in human plasma by liquid chromatography-tandem mass spectrometry. van Giersbergen, P.L., Wipfli, P., Dingemanse, J. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. (2003)
- In vivo and in vitro studies exploring the pharmacokinetic interaction between bosentan, a dual endothelin receptor antagonist, and glyburide. van Giersbergen, P.L., Treiber, A., Clozel, M., Bodin, F., Dingemanse, J. Clin. Pharmacol. Ther. (2002)
- Single- and multiple-dose pharmacokinetics of bosentan and its interaction with ketoconazole. van Giersbergen, P.L., Halabi, A., Dingemanse, J. Br. J. Clin. Pharmacol (2002)
- Cyclosporin increases the exposure to tezosentan, an intravenous dual endothelin receptor antagonist. van Giersbergen, P.L., Bodin, F., Dingemanse, J. Eur. J. Clin. Pharmacol. (2002)
